web_JulioMartinez-Clark

Julio G. Martinez-Clark

Julio G. Martinez-Clark is co-founder and CEO of bioaccess, a market access consultancy that works with medical device companies to help them do early-feasibility clinical trials and commercialize their innovations in Latin America. Julio is also the host of the LATAM Medtech Leaders podcast: A weekly conversation with Medtech leaders who have succeeded in Latin America. He serves as an advisory board member for Stetson University's Leading Disruptive Innovation program. He has a bachelor's degree in electronics engineering and a master's degree in business administration.

ARTICLES BY JULIO G. MARTINEZ-CLARK

  • Colombia: A Strategic Choice For Medtech Clinical Trials
    3/21/2024

    Colombia, one of the top three economies and most populous countries in Latin America, is a promising destination for medical device clinical trials for these reasons.
  • The Landscape For Conducting Medtech Clinical Trials In The Dominican Republic
    9/11/2023

    The Dominican Republic, a Caribbean nation with over 11 million people, is experiencing an upward trend in attracting medical device clinical trials. Let's look at how its healthcare system is constructed, as well as advantages and challenges of conducting medtech clinical research in the country.
  • The Landscape Of Medtech Clinical Research In El Salvador
    6/6/2023

    El Salvador’s economy has transformed radically over the last half century. In recent years, the country now offers several advantages for medtech clinical research, such as a diverse patient population and a favorable regulatory environment.
  • LATAM’s Regulatory Framework For Medtech Early Feasibility Studies
    11/11/2022

    Latin America is a compelling region to conduct medtech early feasibility studies due to its ethnically diverse population, its high rate of urbanization, and more. Here, the author spotlights Colombia, Brazil, and Mexico as the hotspots for medtech feasibility studies in Latin America. 
  • Latin America’s Landscape For Medtech Clinical Trials
    7/5/2022

    This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America, particularly in Colombia and Paraguay. It also addresses critical success factors and provides recommendations to ensure cost-effective, ethical, and quality EFS and FIH medtech clinical trials in the region.
  • Latin America: A Compelling Region To Conduct Your Clinical Trials
    6/7/2022

    This article examines the need to conduct clinical trials outside the U.S., addresses the recruitment crisis in the U.S., reviews the incentives for clinical trials overseas, and explores the growth of clinical trials in Latin America. Colombia is highlighted as a country that stands out as ripe with opportunity.
  • Peru’s Growing Medical Device Market In Latin America
    4/4/2022

    With a population of 32 million, Peru is the fifth most populous country in Latin America. Its medical device market is $390 million, and it imports more than 97% of the medical devices that it uses. This article covers Peru's health system, its medical device regulatory framework, and opportunities for medical device imports.
  • The Large Market For Medical Devices In Colombia May Surprise You
    3/21/2022

    Colombia has a population of approximately 50 million inhabitants, making it the third most populous country in Latin America after Mexico and Brazil. This article covers the general Colombian health social security system, the current medical device regulatory framework, and the size and trends of the market.
  • Argentina’s Thriving Medical Device Market Amid An Economic Plunge
    8/20/2021

    Argentina has Latin America's third biggest economy, outdone only by Brazil and Mexico. This article describes the Argentine healthcare system, regulatory framework for medical devices, and related business opportunities and challenges.
More Articles by Julio G. Martinez-Clark